Samuel Hill, MD
Otolaryngology · Naples, FLNPI 1336176593
Payments from drug & device makers
Across 52 payments — averaging $114.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Aerin Medical Inc.$2K
- Medtronic$338
- Intersect ENT, Inc.$263
- Neurent Medical Limited$152
- Acclarent, Inc$145
- plus $466 from 11 others
What the payments were for
- Consulting fees$4,12569%
- Food & beverage$1,80730%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $2,491 |
| Aerin Medical Inc. | 18 | $2,098 |
| Medtronic | 2 | $338 |
| Intersect ENT, Inc. | 2 | $263 |
| Neurent Medical Limited | 1 | $152 |
| Acclarent, Inc | 3 | $145 |
| Optinose US, Inc. | 5 | $103 |
| GSK | 6 | $99 |
| Xoran Technologies LLC | 1 | $88 |
| Stryker | 2 | $51 |
| Organogenesis Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $23 |
| Amgen | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Smith+Nephew | 1 | $14 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RHINAER STYLUS$1,500
- NUVENT$188
- NEUROMARK Device$152
- NEUROMARK Radiofrequency Console$152
- PROPEL$148
- SINUVA$114
How this compares
$5,952 in reported general payments places this provider in the 80th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $47,008 |
| Azelastine Hcl | 421 | $13,579 |
| Ipratropium Bromide | 259 | $9,095 |
| Fluticasone Propionate | 231 | $3,890 |
| Montelukast Sodium | 188 | $2,620 |
| Levocetirizine Dihydrochloride | 58 | $1,534 |
| Ofloxacin | 52 | $1,512 |
| Famotidine | 86 | $1,218 |
| Fluocinolone Acetonide Oil | 30 | $1,190 |
| Mupirocin | 173 | $1,054 |
| Omeprazole | 56 | $1,052 |
| Esomeprazole Magnesium | 46 | $664 |
| Methylprednisolone | 99 | $605 |
| Triamcinolone Acetonide | 14 | $447 |
| Pantoprazole Sodium | 27 | $432 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Naples
- Leela LavasaniNaples$44K
- James HadleyNaples$33K
- Craig ShapiroHollywood$8.1M
- Adrien EshraghiMiami$2.1M
- Cecelia DamaskOrlando$771K
- Ralph TufanoSarasota$733K
- Mitchell MillerClearwater$709K
- Brian KerrGainesville$629K
- Maria SuurnaMiami$456K
- Mark TaborTampa$348K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.